Inventor · disambiguated record
Paul Bamborough
Also filed as: BAMBOROUGH PAUL · BAMBOROUGH PAUL L
28 granted patents·11 pending applications·255 citations·filing 1999–2016
96Inventor score
Files withGLAXO GROUP LTD12SMITHKLINE BEECHAM CORP9BAMBOROUGH PAUL7GLAXOSMITHKLINE LLC3ASTON NICOLA MARY2
Top patents by PatentIndex Score
39 records- 0192US7125898B2Nicotinamide derivatives useful as p38 inhibitors.SMITHKLINE BEECHAM CORP·Filed 2003·Granted Oct 24, 2006·39 cites·15 claims
- 0290US7309800B2Biphenylcarboxylic amide derivatives as p38 kinase inhibitorsGLAXO GROUP LTD·Filed 2006·Granted Dec 18, 2007·17 cites·13 claims
- 0389US7514456B2Nicotinamide derivatives useful as p38 inhibitorsSMITHKLINE BEECHAM CORP·Filed 2006·Granted Apr 7, 2009·9 cites·10 claims
- 0487US7151118B2Biphenylcarboxylic amide derivatives as p38-kinase inhibitorsGLAXO GROUP LTD·Filed 2002·Granted Dec 19, 2006·27 cites·15 claims
- 0586US7166623B22′-Methyl-5′-(1,3,4-oxadiazol-2-yl)-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitorsGLAXO GROUP LTD·Filed 2002·Granted Jan 23, 2007·22 cites·14 claims
- 0684US7709506B2Nicotinamide derivatives useful as p38 inhibitorsGLAXOSMITHKLINE LLC·Filed 2006·Granted May 4, 2010·5 cites·34 claims
- 0782US7208629B25′-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitorsGLAXO GROUP LTD·Filed 2002·Granted Apr 24, 2007·20 cites·17 claims
- 0881US7384963B22′-Methyl-5-(1,3,4-oxadiazol-2-yl)1, 1′-biphenyl-4-carboxaide derivatives and their use as p38 kinaseGLAXO GROUP LTD·Filed 2002·Granted Jun 10, 2008·15 cites·11 claims
- 0980US7183297B2Biphenyl-derivatives as p38-kinase inhibitorsGLAXO GROUP LTD·Filed 2002·Granted Feb 27, 2007·14 cites·21 claims
- 1079US7432289B25-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitorsGLAXO GROUP LTD·Filed 2002·Granted Oct 7, 2008·14 cites·13 claims
- 1178US7396843B25′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitorsGLAXO GROUP LTD·Filed 2002·Granted Jul 8, 2008·12 cites·20 claims
- 1276US7425555B2Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Sep 16, 2008·13 cites·16 claims
- 1375US7678801B2CompoundsGLAXO GROUP LTD·Filed 2006·Granted Mar 16, 2010·2 cites·76 claims
- 1474US9663533B2Thieno[3,2-C]pyridin-4(5H)-ones as BET inhibitorsGLAXOSMITHKLINE LLC·Filed 2013·Granted May 30, 2017·2 cites·13 claims
- 1574US8778939B2CompoundsNICHOLS PAULA LOUISE·Filed 2010·Granted Jul 15, 2014·7 cites·13 claims
- 1672US9670221B2Furopyridines as bromodomain inhibitorsGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2014·Granted Jun 6, 2017·3 cites·13 claims
- 1771US7642276B2Fused heteroaryl derivatives for use as P38 kinase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Jan 5, 2010·9 cites·16 claims
- 1870US8252818B2Nicotinamide derivatives useful as P38 inhibitorsASTON NICOLA MARY·Filed 2010·Granted Aug 28, 2012·1 cites·2 claims
- 1970US7572790B2Biphenyl carboxylic amide p38 kinase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2004·Granted Aug 11, 2009·5 cites·15 claims
- 2069US8575204B2Nicotinamide derivates useful as P38 inhibitorsASTON NICOLA MARY·Filed 2010·Granted Nov 5, 2013·1 cites·18 claims
- 2165US8207176B2CompoundsCALLAHAN JAMES F·Filed 2006·Granted Jun 26, 2012·1 cites·31 claims
- 2265US2009318472A1Aminopyrazine derivatives and compositionsSMITHKLINE BEECHAM CORP·Filed 2009·Application pending·0 cites
- 2364US8354416B27,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinaseGLAXO GROUP LTD·Filed 2008·Granted Jan 15, 2013·0 cites·30 claims
- 2463US7598251B2Aminopyrazine derivatives and compositionsSMITHKLINE BEECHAM CORP·Filed 2008·Granted Oct 6, 2009·0 cites·4 claims
- 2562US6989395B2Imidazolyl-cyclic acetalsAVENTIS PHARMA LTD·Filed 2003·Granted Jan 24, 2006·1 cites·27 claims
- 2661US9360482B2Process for the identification of a compound which inhibits the binding of the second bromodomain of each of human BRD-2, BRD-3, and BRD-4BAMBOROUGH PAUL·Filed 2010·Granted Jun 7, 2016·1 cites·8 claims
- 2759US6602877B1Imidazolyl-cyclic acetalsAVENTIS PHARMA LTD·Filed 1999·Granted Aug 5, 2003·15 cites·36 claims
- 2855US9753034B2Process for the identification of a compound which inhibits the binding of the first bromodomain of each of human BRD-2, BRD-3, and BRD-4GLAXOSMITHKLINE LLC·Filed 2016·Granted Sep 5, 2017·0 cites·8 claims
- 2954US7459454B2Aminopyrazine derivatives and compositionsSMITHKLINE BEECHAM CORP·Filed 2004·Granted Dec 2, 2008·0 cites·4 claims
- 3053US2007142476A1Biphenyl-Derivatives as p38 Kinase InhibitorsGLAXO GROUP LTD·Filed 2007·Application pending·0 cites
- 3153US2007112046A12'-Methyl-5'-(1,3,4-Oxadiazol-2-yl)-1,1'-Biphenyl-4-Carboxamide Derivatives and Their Use As P38 Kinase InhibitorsGLAXO GROUP LTD·Filed 2006·Application pending·0 cites
- 3251US2008146606A1Novel compoundsBAMBOROUGH PAUL·Filed 2007·Application pending·0 cites
- 3351US2008176891A1Novel compoundsBAMBOROUGH PAUL·Filed 2007·Application pending·0 cites
- 3451US2010035917A1Pyrrolo[2,3-b]pyridin-4-yl-benzenesulfonamide compounds as 1kk2 inhibitorsBAMBOROUGH PAUL·Filed 2007·Application pending·0 cites
- 3542US2005065195A1Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitorsFiled 2002·Application pending·0 cites
- 3641US2010179139A1Pyrrolopyridine compounds, process for their preparation, and their use as medicamentsBAMBOROUGH PAUL·Filed 2008·Application pending·0 cites
- 3739US2008269200A1Indole Derivatives and Use Thereof as Kinase Inhibitors in Particular Ikk2 InhibitorsSMITHKLINE BEECHAM CORP·Filed 2005·Application pending·0 cites
- 3835US2009023725A1Fused Heteroaryl Derivatives for Use as P38 Kinase InhibitorsBAMBOROUGH PAUL·Filed 2005·Application pending·0 cites
- 3933US2007149519A1Benzimidazol substituted thiopene derivatives with activity on ikk3BAMBOROUGH PAUL·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul Bamborough files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →